Vanda Pharmaceuticals (VNDA) FCF Margin Growth (1y) (2011 - 2026)
Vanda Pharmaceuticals (VNDA) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | -3,042.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,042.00 |
| Dec 31, 2025 | -4,777.00 |
| Sep 30, 2025 | -2,556.00 |
| Jun 30, 2025 | -1,563.00 |
| Mar 31, 2025 | -8,304.00 |
| Dec 31, 2024 | 498.00 |
| Sep 30, 2024 | -2,559.00 |
| Jun 30, 2024 | 1,488.00 |
| Mar 31, 2024 | -3,487.00 |
| Dec 31, 2023 | -2,300.00 |
| Sep 30, 2023 | -2,477.00 |
| Jun 30, 2023 | -3,735.00 |
| Mar 31, 2023 | 4,421.00 |
| Dec 31, 2022 | -2,473.00 |
| Sep 30, 2022 | 601.00 |
| Jun 30, 2022 | -1,904.00 |
| Mar 31, 2022 | -786.00 |
| Dec 31, 2021 | 1,182.00 |
| Sep 30, 2021 | -172.00 |
| Jun 30, 2021 | -1,068.00 |